Sleepio
Sleepio is a San Francisco-based digital therapeutics company founded in 2012 that delivers an AI-driven, CBT-I-based program for individuals with insomnia, including an FDA-cleared prescription variant called SleepioRx, distributed via a self-serve web subscription platform.
- Company typePrivate
- Founded2008
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What Sleepio does
Sleepio is a privately held digital therapeutics company founded in 2012 and headquartered in San Francisco that develops an AI-driven platform for the treatment of insomnia and other sleep disorders. Its core product is the Sleepio application, which delivers cognitive behavioral therapy for insomnia (CBT-I) through a web-based digital therapeutic, supported by AI-driven personalization, continuous behavioral monitoring, and AI-assisted sleep diagnostics. A sub-brand, SleepioRx, is FDA-cleared as a digital therapeutic for sleep management, positioning the company as a regulated medical product rather than a general wellness app.
The company operates a direct-to-consumer go-to-market, distributing through a self-serve web platform at sleepio.com that includes an onboarding sleep test, and it generates revenue through subscription-based access to its digital therapeutic program. Clinical effectiveness has been validated in systematic literature, with reported improvement rates of 40-76% in patients using the program. The primary customer segment is individuals suffering from insomnia and sleep disorders, served through both consumer self-service and the prescription-graded SleepioRx clinical channel.
The company is described as having 1-10 employees and discloses a single early-stage funding round from JamJar Investments in 2016. Co-founders Colin Espie, a recognized sleep expert, and Peter Hames lead the venture. Information on partnerships, named enterprise customers, pricing, and recent funding activity is not available in the provided source data, limiting visibility into the company's current commercial scale and strategic direction.
Sleepio firmographics
Firmographics- Name
- Sleepio
- Website
- https://sleepio.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Sleepio is a San Francisco-based digital therapeutics company founded in 2012 that delivers an AI-driven, CBT-I-based program for individuals with insomnia, including an FDA-cleared prescription variant called SleepioRx, distributed via a self-serve web subscription platform.
- Ownership category
- akta.pro rank
Sleepio industry classification
Industry- Product category
- Digital Therapeutics — Sleep Improvement Software
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Sleep Medicine Clinic (HLAKANAB)
- akta.pro secondary industries
- Sleep Health Coaching (HSADAGAE), Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)
Keywords
Where Sleepio is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Sleepio business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Digital Therapeutic Subscription: Sleepio operates as a digital therapeutic offering sleep improvement solutions through its FDA-cleared platform. Revenue is generated through subscription-based access to the digital therapeutic program.
Go-to-market motion1 record
Distribution channels1 record
Sleepio product offering
Product offeringCore offering
Sleepio delivers an AI-powered digital therapeutic platform that treats insomnia and improves sleep quality through Cognitive Behavioral Therapy for Insomnia (CBT-I), personalized sleep improvement programs, and continuous behavioral monitoring. Its flagship consumer product (Sleepio) is delivered via a web-based platform, and its FDA-cleared variant (SleepioRx) is distributed through clinician prescription channels for sleep management as a regulated medical treatment.
Product overview
Sleepio offers a digital therapeutic platform centered on its flagship Sleepio application, which provides AI-driven sleep improvement programs based on cognitive behavioral therapy for insomnia (CBT-I). The platform is referenced alongside SleepioRx as part of the company's digital therapeutic offerings for sleep disorders. Sleepio functions as the primary consumer-facing product delivering personalized sleep assessments, behavioral interventions, and ongoing progress tracking through an AI-powered interface.
Differentiator
Problem solved
Functional benefit
Brands
- SleepioRx: FDA-cleared digital therapeutic for sleep/insomnia treatment.
Products and services
- Sleepio AI-powered digital therapeutic application for individual consumers that treats insomnia and improves sleep quality through Cognitive Behavioral Therapy for Insomnia (CBT-I) techniques, personalized sleep improvement programs, and continuous behavioral monitoring; delivered via web platform (sleepio.com).
- SleepioRx FDA-cleared digital therapeutic formulation of Sleepio for sleep management, distributed via clinician prescription channels as a regulated medical treatment for insomnia.
Quantifiable outcome
- 40% to 76% improvement in patients with insomnia
Companies that use Sleepio
Customer profileSegments1 record
Ideal customer profiles2 records
Sleepio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Sleepio partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Sleepio competitors and assessment
Company assessmentEmerging players
- Dreem: Dreem is a sleep technology company combining a wearable headband with a software-based sleep improvement program. It overlaps with Sleepio in CBT-based sleep improvement and DTC delivery, differing primarily through its hardware component.
- Akili Interactive: Akili Interactive develops FDA-cleared prescription digital therapeutics, primarily for ADHD. It shares the regulatory pathway, prescription distribution model, and digital therapeutic category with Sleepio, though its focus is cognitive rather than sleep.
- Pear Therapeutics: Pear Therapeutics is a prescription digital therapeutic company focused on substance use disorder, opioid use disorder, and insomnia. It shares the FDA-cleared digital therapeutic business model and prescription-channel go-to-market with Sleepio.
Broad incumbents
- Oura: Oura produces the Oura Ring sleep and readiness tracker with an accompanying subscription app. It competes with Sleepio for consumer mindshare on sleep improvement, though Oura focuses on measurement and insights rather than CBT-I delivery.
- BetterHelp: BetterHelp is the largest online therapy platform, delivering CBT-based interventions via digital subscription. It is comparable to Sleepio as an online delivery vehicle for CBT-style therapy, though broader in scope and without FDA-cleared indications.
- Whoop: Whoop is a wearable-based sleep and recovery tracking platform with a membership model. It overlaps with Sleepio in the consumer sleep-improvement subscription category, differing in its hardware-first approach versus Sleepio's therapy-first approach.
Direct peers
- Calm: Calm is a leading consumer sleep and meditation app with Sleep Stories and a DTC subscription model. It competes directly with Sleepio in the consumer sleep-improvement category, though Calm is broader in scope and not FDA-cleared.
- Somryst: Somryst (previously SHUTi) is a prescription digital therapeutic for chronic insomnia using CBT-I, with FDA clearance. It is the most direct FDA-cleared competitor to Sleepio in the digital prescription CBT-I category.
- Headspace Health: Headspace offers sleep and meditation content via a DTC subscription and B2B channel. It overlaps directly with Sleepio on the sleep use case and shares a similar consumer-therapeutic positioning, though without FDA clearance.
- Big Health: Big Health develops digital therapeutics for sleep (Sleepio is closely associated with its product line historically) and anxiety (Daylight). It is the most direct functional competitor in the FDA-cleared digital sleep therapeutic space and shares the CBT-I foundation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Sleepio social profiles
Digital presenceSleepio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sleepio leadership team
Management profileNumber of profiles
Profiles2 records
Sleepio funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sleepio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sleepio
What does Sleepio do?
Sleepio delivers an AI-powered digital therapeutic platform that treats insomnia and improves sleep quality through Cognitive Behavioral Therapy for Insomnia (CBT-I), personalized sleep improvement programs, and continuous behavioral monitoring. Its flagship consumer product (Sleepio) is delivered via a web-based platform, and its FDA-cleared variant (SleepioRx) is distributed through clinician prescription channels for sleep management as a regulated medical treatment.
Is Sleepio a public or private company?
Sleepio is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sleepio founded?
Sleepio was founded in 2008. It employs 1 to 10 people.
Where is Sleepio based?
Sleepio is headquartered in San Francisco, United States, in the North America region.
How does Sleepio make money?
One revenue line is on record: digital Therapeutic Subscription.
Who are Sleepio's main competitors?
Emerging players on record are Dreem, Akili Interactive and Pear Therapeutics. Broad incumbents are Oura, BetterHelp and Whoop. Direct peers are Calm, Somryst, Headspace Health and Big Health.
Does Sleepio have an API?
No public API is recorded for Sleepio.
What industry is Sleepio in?
Sleepio's product category is Digital Therapeutics — Sleep Improvement Software. Its primary akta.pro industry code is HLAKANAB, Sleep Medicine Clinic, with a secondary code of HSADAGAE, Sleep Health Coaching. Its NAICS code is 6219 and its SIC code is 8000.